Duncan Jason 4
4 · Neumora Therapeutics, Inc. · Filed Dec 12, 2023
Insider Transaction Report
Form 4
Duncan Jason
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-12-11+400,000→ 400,000 totalExercise: $12.97Exp: 2033-12-10→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from December 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.